Li et al. conducted a population-based cross-sectional study on 1,608 cases with normal ALT categorized as obese and non-obese patients and found that TG was associated with a 2.54-fold increase in NAFLD among non-obese subjects (30). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.